Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription


1 Am J Gastroenterol
2 Am J Pathol
1 Anticancer Res
4 Biochem Biophys Res Commun
3 BMC Cancer
3 BMC Gastroenterol
2 Br J Surg
4 Dig Dis
2 Dig Dis Sci
4 Eur Radiol
4 Hepatology
1 Indian J Gastroenterol
4 J Hepatol
1 Lancet
1 Oncogene
1 PLoS One
1 Radiology
2 Transplant Proc

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Gastroenterol

  1. MA C, Qian AS, Nguyen NH, Stukalin I, et al
    Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016.
    Am J Gastroenterol. 2021 Apr 28. doi: 10.14309/ajg.0000000000001292.
    PubMed         Abstract available

    Am J Pathol

  2. CHEN Z, Jiang L, Liang L, Koral K, et al
    The Role of Fibroblast Growth Factor 19 in Hepatocellular Carcinoma.
    Am J Pathol. 2021 May 14. pii: S0002-9440(21)00198.
    PubMed         Abstract available

  3. ZHANG Y, Liang B, Song X, Wang H, et al
    Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice.
    Am J Pathol. 2021;191:930-946.
    PubMed         Abstract available

    Anticancer Res

  4. NISHIKAWA H, Fukunishi S, Asai A, Nishiguchi S, et al
    Obesity and Liver Cancer in Japan: A Comprehensive Review.
    Anticancer Res. 2021;41:2227-2237.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  5. FAN Z, Gao Y, Zhang W, Yang G, et al
    METTL3/IGF2BP1/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC.
    Biochem Biophys Res Commun. 2021;546:169-177.
    PubMed         Abstract available

  6. YANG M, Cui Y, Song J, Cui C, et al
    Mesenchymal stem cell-conditioned medium improved mitochondrial function and alleviated inflammation and apoptosis in non-alcoholic fatty liver disease by regulating SIRT1.
    Biochem Biophys Res Commun. 2021;546:74-82.
    PubMed         Abstract available

  7. WANG Y, Yang H, Zhang G, Luo C, et al
    hsa-miR-7-5p suppresses proliferation, migration and promotes apoptosis in hepatocellular carcinoma cell lines by inhibiting SPC24 expression.
    Biochem Biophys Res Commun. 2021;561:80-87.
    PubMed         Abstract available

  8. YUAN Y, Yuan HF, Geng Y, Zhao LN, et al
    Aspirin modulates 2-hydroxyisobutyrylation of ENO1K281 to attenuate the glycolysis and proliferation of hepatoma cells.
    Biochem Biophys Res Commun. 2021;560:172-178.
    PubMed         Abstract available

    BMC Cancer

  9. ZHANG Z, Zhao X, Li Z, Wu Y, et al
    Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
    BMC Cancer. 2021;21:567.
    PubMed         Abstract available

  10. HONG YM, Yoon KT, Cho M
    Systemic immune-inflammation index predicts prognosis of sequential therapy with sorafenib and regorafenib in hepatocellular carcinoma.
    BMC Cancer. 2021;21:569.
    PubMed         Abstract available

  11. LI Z, Wang C, Li J, Liu Z, et al
    MR-guided microwave ablation of hepatocellular carcinoma (HCC): is general anesthesia more effective than local anesthesia?
    BMC Cancer. 2021;21:562.
    PubMed         Abstract available

    BMC Gastroenterol

  12. OKAMURA T, Hashimoto Y, Hamaguchi M, Obora A, et al
    Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study.
    BMC Gastroenterol. 2021;21:223.
    PubMed         Abstract available

  13. GUNDA DW, Mtui EF, Manyiri PM, Majinge DC, et al
    Schistosoma mansoni-related periportal fibrosis; can we use APRI and PSDR levels in the real-time selection of patients for targeted endoscopy in a resource-limited setting? A case-control study.
    BMC Gastroenterol. 2021;21:219.
    PubMed         Abstract available

  14. PENG H, Xie X, Pan X, Zheng J, et al
    Association of meat consumption with NAFLD risk and liver-related biochemical indexes in older Chinese: a cross-sectional study.
    BMC Gastroenterol. 2021;21:221.
    PubMed         Abstract available

    Br J Surg

  15. LAYTON GR, Chung WY, Isherwood J, Fraser RE, et al
    Endoscopic retrograde cholangiopancreatography in the COVID era: considerations for hepatobiliary and pancreatic surgery units.
    Br J Surg. 2021 May 17. pii: 6277144. doi: 10.1093.

  16. HOBEIKA C, Cauchy F
    Reply: Can laparoscopic approach improve quality of care of patients with resectable intrahepatic cholangiocarcinoma? (Comment on 'laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis').
    Br J Surg. 2021 May 17. pii: 6277143. doi: 10.1093.

    Dig Dis

  17. WADA N, Uojima H, Satoh T, Okina S, et al
    Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease.
    Dig Dis. 2021;39:234-242.
    PubMed         Abstract available

  18. XU Y, Hu X, Li J, Dong R, et al
    An Improved Scoring System Based on Platelet-Albumin-Bilirubin in Predicting Posthepatectomy Liver Failure Outcomes.
    Dig Dis. 2021;39:258-265.
    PubMed         Abstract available

  19. WEBER S, Benesic A, Buchholtz ML, Rotter I, et al
    Antimitochondrial Rather than Antinuclear Antibodies Correlate with Severe Drug-Induced Liver Injury.
    Dig Dis. 2021;39:275-282.
    PubMed         Abstract available

  20. BARABAS L, Hritz I, Istvan G, Tulassay Z, et al
    The behavior of MMP-2, MMP-7, MMP-9 and their inhibitors TIMP-1, TIMP-2 in adenoma-colorectal cancer sequence.
    Dig Dis. 2020 Sep 22. pii: 000511765. doi: 10.1159/000511765.
    PubMed         Abstract available

    Dig Dis Sci

  21. SERPER M
    Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07020.

  22. BLOOM PP, Ventoso M, Tapper E, Ha J, et al
    A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving.
    Dig Dis Sci. 2021 May 6. pii: 10.1007/s10620-021-07013.
    PubMed         Abstract available

    Eur Radiol

  23. OBMANN VC, Berzigotti A, Catucci D, Ebner L, et al
    T1 mapping of the liver and the spleen in patients with liver fibrosis-does normalization to the blood pool increase the predictive value?
    Eur Radiol. 2021;31:4308-4318.
    PubMed         Abstract available

  24. JIANG H, Song B, Qin Y, Chen J, et al
    Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
    Eur Radiol. 2021;31:3638-3648.
    PubMed         Abstract available

  25. MIN JH, Kim SH, Hwang JA, Hyun SH, et al
    Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.
    Eur Radiol. 2021;31:3649-3660.
    PubMed         Abstract available

  26. HECTORS SJ, Kennedy P, Huang KH, Stocker D, et al
    Fully automated prediction of liver fibrosis using deep learning analysis of gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:3805-3814.
    PubMed         Abstract available


  27. LAMARCA A, Santos-Laso A, Utpatel K, La Casta A, et al
    Reply to (20-1119.R1) Surgery for advanced intrahepatic cholangiocarcinoma warrants further investigation.
    Hepatology. 2021 May 17. doi: 10.1002/hep.31904.
    PubMed         Abstract available

  28. JANSSON H, Sparrelid E
    Letter to the Editor: The role of surgery in multiple intrahepatic cholangiocarcinoma should not be dismissed without further analysis.
    Hepatology. 2021 May 18. doi: 10.1002/hep.31905.
    PubMed         Abstract available

  29. BAJAJ JS, Garcia-Tsao G, Reddy KR, O'Leary JG, et al
    Admission urinary and serum metabolites predict renal outcomes in hospitalized patients with cirrhosis.
    Hepatology. 2021 May 18. doi: 10.1002/hep.31907.
    PubMed         Abstract available

  30. MEHTA G, Jalan R
    The 'Alter Ego' of Albumin in Cirrhosis.
    Hepatology. 2021 May 18. doi: 10.1002/hep.31908.
    PubMed         Abstract available

    Indian J Gastroenterol

  31. PAMECHA V, Sinha PK, Rajendran V, Patil NS, et al
    Living donor liver transplantation for hepatocellular carcinoma in Indian patients- Is the scenario different?
    Indian J Gastroenterol. 2021 May 21. pii: 10.1007/s12664-020-01138.
    PubMed         Abstract available

    J Hepatol

  32. PINYOL R, Torrecilla S, Wang H, Montironi C, et al
    Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.
    J Hepatol. 2021 May 13. pii: S0168-8278(21)00326.
    PubMed         Abstract available

  33. ZHOU HC, Liu CX, Pan WD, Shang LR, et al
    Dual and opposing roles of the androgen receptor in VETC-dependent and invasion-dependent metastasis of hepatocellular carcinoma.
    J Hepatol. 2021 May 15. pii: S0168-8278(21)00331.
    PubMed         Abstract available

  34. NAN Y, An J, Bao J, Chen H, et al
    The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease.
    J Hepatol. 2021 May 18. pii: S0168-8278(21)00332.
    PubMed         Abstract available

  35. WANG H, Wen B, Chen J
    "Small esophageal varices in compensated cirrhosis patients: to treat or not to treat?" -Reply.
    J Hepatol. 2021 May 18. pii: S0168-8278(21)00335.


  36. WILLIAMS R, Alessi C, Alexander G, Allison M, et al
    New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK.
    Lancet. 2021 Mar 10. pii: S0140-6736(20)32396.
    PubMed         Abstract available


  37. CAROTTI S, Zingariello M, Francesconi M, D'Andrea L, et al
    Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge.
    Oncogene. 2021 May 20. pii: 10.1038/s41388-021-01824.
    PubMed         Abstract available

    PLoS One

  38. JOBIRA B, Frank DN, Silveira LJ, Pyle L, et al
    Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
    PLoS One. 2021;16:e0245219.
    PubMed         Abstract available


  39. BAI XM, Cui M, Yang W, Wang H, et al
    The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Radiology. 2021 May 18:200153. doi: 10.1148/radiol.2021200153.
    PubMed         Abstract available

    Transplant Proc

  40. YOON YI, Lee SG, Moon DB, Park GC, et al
    Microsurgical Hepatic Artery Reconstruction in Deceased Donor Liver Transplantation for Reduced Arterial Complications.
    Transplant Proc. 2021 May 14. pii: S0041-1345(21)00256.
    PubMed         Abstract available

  41. WELLER A, Seyfried T, Ahrens N, Baier-Kleinhenz L, et al
    Cell Salvage During Liver Transplantation for Hepatocellular Carcinoma: A Retrospective Analysis of Tumor Recurrence Following Irradiation of the Salvaged Blood.
    Transplant Proc. 2021 May 13. pii: S0041-1345(21)00218.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.